Zacks Small Cap Research on MSN2d
DWTX: Interim Data for Phase 2b Trial in 4Q25…
DWTX READ THE FULL DWTX RESEARCH REPORT Business Update First Patient Dosed in Phase 2b Trial of Halneuron® On March 18, 2025 ...
Pain is a complex physiological and psychological phenomenon that is subjective in nature. Pain is still one of the most ...
Anyone who suffers from chronic low back pain knows how difficult it can be to manage, and how quickly it can turn the most ...
Painful diabetic neuropathy was associated with lower quality of life and higher rates of depression and anxiety than painless diabetic neuropathy.
From our new flagship facility in Houston, Texas, our experienced team will Change Lives for a Better World as we scale production ... addressing neuropathic and mechanical pain," said Rohan ...
Opioid-free and addiction-free pain treatment therapy could address $1.5B worldwide CINP market “Our goal is to recruit 100 patients with CINP by the fourth quarter of 2025, which should allow us to ...
But it only reduced the intensity of pain by an average of 7.9 points on a 0-to-100 pain scale — less than what most doctors consider to be a clinically meaningful difference. Say a patient ...
Many people are in pain due to neuropathic pain i.e. a disorder in the nervous system. So, problems with the muscles also trouble people. In such a situation, to get relief from bone or joint pain ...
The generalizability of new drugs developed based on related research on neuropathic pain in PHN patients is unknown. Therefore, it is necessary to conduct large-scale studies on neuroimaging, ...
Yet, this is the very essence of the common 0-to-10 pain scale used in healthcare. Asking kids to understand 'ten'—the 'worst pain imaginable'—revealed the inherent limitations of this ...
Neuroscientists have shown that experiencing nature can alleviate acute physical pain. Surprisingly, simply watching nature videos was enough to relieve pain. Using functional magnetic resonance ...
This advancement expands the Company’s pain management portfolio beyond its ongoing Ketamir-2 oral treatment for neuropathic pain, offering a novel, targeted approach for localized pain relief. “The ...